Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S S Taneja

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Prostate Cancer and Prostatic Diseases|December 24, 2002
The role of androgen receptor coactivators in prostate cancer growthS S Taneja
The Journal of Urology|November 4, 2000
Molecular markers of cancer progression. Ready or not, here they comeS S Taneja
The Journal of Urology|May 1, 1997
Refining the gold standard--can we do better with serum prostate specific antigen in the detection of prostate cancer?S S Taneja
Prostate Cancer and Prostatic Diseases|October 3, 2007
Contemporary clinical management of isolated high-grade prostatic intraepithelial neoplasiaG Godoy, S S Taneja
Molecular Medicine Today|December 19, 1998
Prospects for gene therapy in human prostate cancerM A Ficazzola, S S Taneja
Urology|August 8, 2001
Volume-specific cutoffs are necessary for reproducible application of prostate-specific antigen density of the transition zone in prostate cancer detectionS S Taneja, K Tran, H Lepor
Journal of Cellular Biochemistry|December 18, 2001
Androgen stimulated cellular proliferation in the human prostate cancer cell line LNCaP is associated with reduced retinoblastoma protein expressionS S Taneja, S Ha, M J Garabedian
Urology|June 1, 1995
Immunotherapy for renal cell carcinoma: the era of interleukin-2-based treatmentS S Taneja, W Pierce, R Figlin, et al.
Cancer Surveys|January 1, 1995
Gene therapy: principles and potentialS S Taneja, S Pang, P Cohan, et al.
The Urologic Clinics of North America|November 1, 1994
Management of disseminated kidney cancerS S Taneja, W Pierce, R Figlin, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Prostate Cancer and Prostatic Diseases|December 24, 2002
The role of androgen receptor coactivators in prostate cancer growthS S Taneja
The Journal of Urology|November 4, 2000
Molecular markers of cancer progression. Ready or not, here they comeS S Taneja
The Journal of Urology|May 1, 1997
Refining the gold standard--can we do better with serum prostate specific antigen in the detection of prostate cancer?S S Taneja
Prostate Cancer and Prostatic Diseases|October 3, 2007
Contemporary clinical management of isolated high-grade prostatic intraepithelial neoplasiaG Godoy, S S Taneja
Molecular Medicine Today|December 19, 1998
Prospects for gene therapy in human prostate cancerM A Ficazzola, S S Taneja
Urology|August 8, 2001
Volume-specific cutoffs are necessary for reproducible application of prostate-specific antigen density of the transition zone in prostate cancer detectionS S Taneja, K Tran, H Lepor
Journal of Cellular Biochemistry|December 18, 2001
Androgen stimulated cellular proliferation in the human prostate cancer cell line LNCaP is associated with reduced retinoblastoma protein expressionS S Taneja, S Ha, M J Garabedian
Urology|June 1, 1995
Immunotherapy for renal cell carcinoma: the era of interleukin-2-based treatmentS S Taneja, W Pierce, R Figlin, et al.
Cancer Surveys|January 1, 1995
Gene therapy: principles and potentialS S Taneja, S Pang, P Cohan, et al.
The Urologic Clinics of North America|November 1, 1994
Management of disseminated kidney cancerS S Taneja, W Pierce, R Figlin, et al.
Pageof 3